StockPriceToday
Paychex Inc (PAYX)
About Paychex Inc
Paychex Inc. provides integrated human capital management solutions including payroll, benefits administration, human resources, and insurance services for small and medium-sized businesses. The company's essential services for small businesses have made PAYX stock price relatively stable with growth tied to small business formation and employment trends.
Paychex's payroll processing services handle wage calculations, tax filings, and compliance requirements for thousands of businesses across various industries. The company's technology platform automates complex payroll tasks while ensuring accuracy and regulatory compliance.
The company's human resources services include benefits administration, worker's compensation insurance, and HR consulting that help small businesses manage their workforce effectively. Paychex's expansion into retirement services and time and attendance systems provides additional revenue opportunities, influencing PAYX stock price movements.
Paychex's focus on customer service and technology innovation has enabled it to maintain market leadership in small business services. The company's recurring revenue model and defensive business characteristics make it attractive to income-focused investors while its market expansion efforts drive continued growth.
PAYX Stock 12 Month Chart
Latest News for PAYX
A December filing shows that Senator Shelley M Capito reported a sale in Paychex (NASDAQ: PAYX ), valued between $2,002 and $30,000. The transaction date is listed as November 13, 2025, with the ...
Valued at a market cap of $39.9 billion, Paychex, Inc. (PAYX) is a leading provider of human capital management (HCM) solutions for small and medium-sized businesses. The Rochester, New York-based ...
Paychex, Inc. (NASDAQ: PAYX) will release earnings results for the first quarter before the opening bell on Tuesday, Sept. 30. Analysts expect the company to report quarterly earnings at $1.20 per ...
Other Popular Stocks
Cogent Biosciences Inc. (COGT) is a biotechnology company focused on developing precision therapies for patients with genetically defined diseases, particularly rare disorders and oncology...
Amylyx Pharmaceuticals Inc. is a biotechnology company developing therapies for neurodegenerative diseases using novel therapeutic approaches.
Aardvark Therapeutics Inc. is a biotechnology company focused on developing innovative treatments for rare diseases and genetic disorders.